Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Companies / United Kingdom

Ardana Launches Breakthrough Incontinence Drug

November 2006 | Product Launch

Switzerland's Novartis and local firm Ardana have launched Emselex (darifenacin) in the UK for the treatment of overactive bladder (OAB). BMI expects the product to post strong sales given its improved side-effect profile compared to existing therapeutics.

Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *


If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.

Western Europe InsightWestern Europe Channels Western Europe Countries